Hypertension and Heart Failure: Prevention, Targets, and Treatment

Katherine E. Di Palo; Nicholas J. Barone

doi:10.1016/j.hfc.2019.09.001

Hypertension and Heart Failure: Prevention, Targets, and Treatment

Katherine E. Di Palo, Nicholas J. Barone

Medicine

Research output: Contribution to journal › Review article › peer-review

92 Scopus citations

Abstract

Hypertension is possibly the most powerful, modifiable risk factor for the development of heart failure. Chronic hypertension drives cardiac remodeling within the left ventricle resulting in hypertensive heart disease, which ultimately manifests as heart failure. Early detection and appropriate management are necessary to prevent heart failure as well as other cardiovascular diseases. Achieving blood pressure goals in conjunction with using evidence-based treatments can improve clinical outcomes for patients with comorbid hypertension and heart failure.

Original language	English (US)
Pages (from-to)	99-106
Number of pages	8
Journal	Heart Failure Clinics
Volume	16
Issue number	1
DOIs	https://doi.org/10.1016/j.hfc.2019.09.001
State	Published - Jan 2020

Keywords

Heart failure
Hypertension
Pharmacotherapy
Risk reduction

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.hfc.2019.09.001

Cite this

@article{73c2d3a988f443f783da97f92a64f2cb,

title = "Hypertension and Heart Failure: Prevention, Targets, and Treatment",

abstract = "Hypertension is possibly the most powerful, modifiable risk factor for the development of heart failure. Chronic hypertension drives cardiac remodeling within the left ventricle resulting in hypertensive heart disease, which ultimately manifests as heart failure. Early detection and appropriate management are necessary to prevent heart failure as well as other cardiovascular diseases. Achieving blood pressure goals in conjunction with using evidence-based treatments can improve clinical outcomes for patients with comorbid hypertension and heart failure.",

keywords = "Heart failure, Hypertension, Pharmacotherapy, Risk reduction",

author = "{Di Palo}, {Katherine E.} and Barone, {Nicholas J.}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = jan,

doi = "10.1016/j.hfc.2019.09.001",

language = "English (US)",

volume = "16",

pages = "99--106",

journal = "Heart Failure Clinics",

issn = "1551-7136",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Hypertension and Heart Failure

T2 - Prevention, Targets, and Treatment

AU - Di Palo, Katherine E.

AU - Barone, Nicholas J.

PY - 2020/1

Y1 - 2020/1

N2 - Hypertension is possibly the most powerful, modifiable risk factor for the development of heart failure. Chronic hypertension drives cardiac remodeling within the left ventricle resulting in hypertensive heart disease, which ultimately manifests as heart failure. Early detection and appropriate management are necessary to prevent heart failure as well as other cardiovascular diseases. Achieving blood pressure goals in conjunction with using evidence-based treatments can improve clinical outcomes for patients with comorbid hypertension and heart failure.

AB - Hypertension is possibly the most powerful, modifiable risk factor for the development of heart failure. Chronic hypertension drives cardiac remodeling within the left ventricle resulting in hypertensive heart disease, which ultimately manifests as heart failure. Early detection and appropriate management are necessary to prevent heart failure as well as other cardiovascular diseases. Achieving blood pressure goals in conjunction with using evidence-based treatments can improve clinical outcomes for patients with comorbid hypertension and heart failure.

KW - Heart failure

KW - Hypertension

KW - Pharmacotherapy

KW - Risk reduction

UR - http://www.scopus.com/inward/record.url?scp=85074883200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074883200&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2019.09.001

DO - 10.1016/j.hfc.2019.09.001

M3 - Review article

C2 - 31735319

AN - SCOPUS:85074883200

SN - 1551-7136

VL - 16

SP - 99

EP - 106

JO - Heart Failure Clinics

JF - Heart Failure Clinics

IS - 1

ER -

Hypertension and Heart Failure: Prevention, Targets, and Treatment

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this